Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

Expert Strategies for Management of Post-Cardiotomy Cardiogenic Shock

Scott Silvestry, MD, and a panel of surgeons take a comprehensive look at post-cardiotomy cardiogenic shock and its management today.

Impact of Impella® on Dissected Coronary Artery Hemodynamics

Kiyotake Ishikawa, MD, discusses his paper on the impact of Impella on dissected coronary artery hemodynamics in a porcine model.

Optimizing Patient Outcomes in Acute Severe Mitral Regurgitation

Christophe Vandenbriele, MD, discusses data on combining Impella® with MitraClip to optimize outcomes in cardiogenic shock with acute severe mitral regurgitation secondary to AMI.

SmartAssist® Technology Cardiac Output Metrics for Patient Management and Weaning

Dave Weber, PhD, reviews how SmartAssist technology determines and tracks trends in cardiac output (CO) and cardiac power output (CPO) and how these metrics can be used to guide a successful Impella® heart pump weaning procedure.

OR and ICU Checklist Best Practices for Impella 5.5® with SmartAssist®

These checklists include steps to perform pre-insertion, during insertion, post-insertion, prior to leaving the OR, and daily in the ICU

Using Echocardiography for Impella® Positioning

TTE videos of proper and improper Impella CP® position

Single Access During Impella® Hemodynamic Support

Matthew G. Whitbeck, MD, describes how the RAILWAY Sheathless Access System can be used with the single access technique.

First Experience with ECMELLA/ECpella

Benedikt Schrage, MD, is one of the first to publish his experience with ECMO and Impella®—a combination known as “ECpella”.

Role of the PA Catheter in Managing Cardiogenic Shock

Complete hemodynamic profiling is associated with lower in-hospital mortality.

Impella 5.5® with SmartAssist® versus CentriMag™: Head-to-Head Comparison of Device Hemocompatibility

Marvin Slepian, MD, compares the hemocompatibility of Impella 5.5 to Centrimag discussing hemolysis, platelet activation, microparticle generation, and vWF alteration.

Complex Protected PCI Case with Thom Dahle, MD: Recorded Live with Panel Discussion 

Thom Dahle, MD, performs a percutaneous axillary Impella®-supported high-risk PCI procedure recorded live with panel discussion.

Efficacy and Safety of all Impella® Use in Japanese Patients With Drug-Resistant Acute HF: Insight From Japan J-PVAD Study

Junya Ako, MD, presents the interim analysis of data from 819 patients from the Japanese Registry for Percutaneous VAD (J-PVAD).

Clinical Relevance of Revascularization Extent in Protected PCI: Insight From Italian Studies

Francesco Burzotta, MD, discusses the clinical impact of revascularization extent in Protected PCI.

Achieving >70% AMICS Survival: Insights From National Cardiogenic Shock Initiative Study

William O'Neill, MD, shares insights from the National Cardiogenic Shock Initiative (NCSI) Study that are driving improved outcomes in patients with AMI cardiogenic shock. 

Review RECOVER III and RECOVER IV Studies

William O’Neill, MD, reviews RECOVER III study data and introduces the RECOVER IV study.

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].